1.Percutaneous nephrolithotomy percutaneous alcohol injection treatment of 45 patients with renal cysts evaluation
Journal of Chongqing Medical University 2007;0(10):-
Objective:To assess the method and the curative effect of percutaneous puncture aspiration and sclerosing treatment of renal cyst under CT-guidance.Methods:58 renal cysts in 45cases diagnosed with ultrasonography or CT were treated with repeated sclerotherapy by percutaneous puncture aspiration and 99.7% ethanol injection.A 18~21G gauge aspiration needle was used for all patients;the amount of administration of ethanol was 25%~30% of the aspirated amount of cyst fluid.Its effect was reviewed and analyzed every four months after operation.Results:The puncture was completed in 53 cysts one time.The patients followed up three months to one year,35 renal cysts in 25 patients disappeared;18 renal cysts in 15 patients reduced in size;and 5 renal cysts in 5 patients had no change.The effective rate was 91.3%.The disappearance rate was 60.3%.There were no serious complications.Conclusion:The sclerosing treatment percutaneous puncture aspiration of renal cyst under CT-guidance is a safe and effective method,and it is of significant value in application.
2.Investigation on the imaging features and value of multilayer spiral CT in diagnosis of pulmonary embolism
China Medical Equipment 2014;(6):101-103
Objective:To investigate the diagnostic valuation of multilayer spiral CT pulmonary angiography in pulmonary embolism. Methods:A retrospective analysis 22 cases of pulmonary embolism were performed by 16 slice spiral CT diagnosis, The volume data of all cases were reconstructed for image post-processing with multi-plane reconstruction, maximum intensity projection and volume rendering. Results: Pulmonary embolism in patients with 22 cases, pulmonary artery and its branches remobilization of 22 cases were demonstrated well by MSCTA. Conclusion:The 16 slice spiral CT in the diagnosis of pulmonary embolism in a safe, rapid, high sensitivity, reliable diagnosis advantages, has been used as first choice of imaging diagnosis of pulmonary embolism diagnosis methods. It is worthy of wide clinical application.
3.Australia medical laboratory process and its reference to Chinese medical laboratories
Chinese Journal of Hospital Administration 2011;27(8):636-638
It summaried the characteristics of Australian laboratory records and laboratory reports, explored the application of clinical laboratory. In order to provide some useful inspiration for domestic laboratory standardized management of the laboratory records and laboratory reports, it proposed laboratory management recommendations, including emphasizing on the laboratory process records, the integrity of laboratory reports and the correctness of laboratory results, strengthening the laboratory report Remarks functions to increase the added value, cultivating clinical awareness of the clinical tests to enhance communication, and staff attached to the specimen and test data preservation
4.Discussion on the Developmental Strategy of Chinese Pharmaceutical Enterprises after Entering WTO
China Pharmacy 2001;0(11):-
OBJECTIVE:To discuss about the developmental strategy of Chinese pharmaceutical enterprises after entering WTO METHODS:To put forward the developmental strategy of Chinese pharmaceutical enterprises,through analyzing the present conditions of Chinese pharmaceutical enterprises and the facing challenges after entering WTO RESULTS & CONCLUSION:Chinese pharmaceutical enterprises can adopt integral strategy,attack strategy,brand strategy,scientific research innovation strategy to improve their market competitive ability
5.Status Quo and Suggestions on Pharmaceutical Administration in Primary Level Medical Institutions
China Pharmacy 1991;0(05):-
OBJECTI VE:To arouse the attention of pri marylevel medical institutions to the pharmaceutical administrationwork.METHODS:Rational proposals and strategies ai med at the problems were put forward by investigation the status quo ofthe pharmaceutical administrationinthe pri marylevel medical institutions.RESULTS &CONCLUSIONS:Policies andlaws ®ulations should be strengthenedin the pri mary level medical institutions so as to i mprove their cognition on pharmaceuticaladministration ; hardware facilities should be i mproved so as to establish a favorable hospital i mage ; Supervision should bestrengthened to facilitate the launching of pharmaceutical administration extensively ;‘People -centered’approach should beemphasized and fully attention should be given to the culture of talents.
7.Influence of Tiaoxie Wan on Blood Lipid and Glucose Metabolism of the Patients with Metabolic Syndrome:A Report of 62 Cases
Journal of Traditional Chinese Medicine 1992;0(08):-
Objective To evaluate the clinical effect of Tiaoxie Wan(Chinese medicine for regulating the metabolic functions)on the metabolic syndrome.Methods Under the condition without changing their original treatment,the 62 metabolic syndrome patients were administered Tiaoxie Wan for oral taking in succession for 2 months.The blood lipid,glycolated hemoglobin(HbA1C),fasting insulin(FINS),insulin action index(IAI),body mass index(BMI),and the clinical effect of main symptoms were observed.Results After treatment,the symptoms such as dizziness,dry mouth,constipation,abdominal distention,and hot temper with irritability were significantly relieved,the total effective rate was all above 85%.The BMI,blood lipid,and HbA1C were significantly decreased,while the FINS and IAI were significantly increased(P
8.Studies on Chemical Constituents of Rhizome of Sheathstipe Greenbrier (Smilax stans)
Chinese Traditional and Herbal Drugs 1994;0(08):-
From the rhizome of Smilax stans Maxim., nine compounds were isolated and their structures were determined to be friedelin, diosgenin, 3, 5, 4'-trihydroxy stilbene, 3, 5, 3',4' -tetrahydroxy stilbene, n-butanol- O-?- D-fructopyranoside, sitosterol-3-O-?- D-glucoside,dioscin, methyl protodioscin and pseudo protodioscin on the basis of chemical,spectral methods and comparison with authentic samples.
9.Treatment of 26 Cases of Chronic Severe Hepatitis with Modified Yinchen Zhufu Decoction
International Journal of Traditional Chinese Medicine 2008;30(5):350,352-
Objective To observe the effect of treating chronic severe hepatitis modified Yinchen Zhufu Decoction.Methods 46 chronic severe hepatitis patients (belonging to Ymhuang syndrome in TCM) were randomly recruited in to a treatment group (26 cases) and a control group (20 cases). Indexes as symptoms, signs, liver functions, prothrombin activity (PTA), prothrombin (ALB) and complications were used for evaluating therapeutic effects. Results After four weeks' treatment, of all 26 cases in the treatment group, 23 cases were effective (occupying 88.5%) and 3 cases were inefficacy (occupying 11.5%); while of all 20 cases in the control group, 11 cases were effective (occupying 55%) and 9 cases were inefficacy (occupying 45%). There was significant difference between the two group in therapeutic effects( P<0.05 ). TBIL in both groups were decreased after the treatment(P< 0.05 ), and the decrease amplitude in the treatment group was much bigger than the control group (P<0.05). PTA in the treatment group was increased after the treatment (P<0.05), but this increase amplitude showed no significant difference comparing with the control group (P>0.05). ALB showed significant difference between the two groups after treatment, with P<0.05, but complications demonstrated no significant difference between the two groups after treatment, with P>0.05. Conclusion Modified Yinchen Zhufu Decoction has good therapeutic effects in treating chronic severe hepatitis of yinhuang syndrome.
10.Clinical Observation of Weifuchun Tablet Combined with Rabeprazole Enteric-coated Tablet in the Treat-ment of Chronic Gastritis with Reflux Esophagitis
China Pharmacy 2016;(6):752-754,755
OBJECTIVE:To observe the efficacy and safety of weifuchun tablet combined with rabeprazole enteric-coated tablet in the treatment of chronic gastritis with reflux esophagitis. METHODS:894 gastritis patients with reflux esophagitis were random-ly divided into control group (407 cases) and observation group (487 cases). Control group was given 10 mg Rabeprazole enter-ic-coated tablet,once a day;observation group was additionally given 1 440 mg Weifuchun tablet,orally,3 times a day. The treat-ment course for both groups was 4-8 weeks. Clinical efficacy,microscopic examination grading,total symptom scores,self-rating anxiety scores(SAS),self-rating depression scores(SDS),quality of life scale score(QOLS),Memorial University of Newfound-land Scale of Happiness score(MUNSH) of reflux esophagitis before and after treatment,and incidence of adverse reactions in 2 groups were observed. RESULTS:The total effective rate in observation group was significantly higher than control group,the dif-ference was statistically significant(P<0.01). Before treatment,there were no significant differences in the microscopic examina-tion grading,symptom scores,SAS,SDS,QOLS and MUNSH scores between 2 groups (P>0.05);after treatment,the micro-scopic examination grading cases in 2 groups were significantly superior to before,observation group was superior to control group,total symptom scores,SAS and SDS scores were significantly lower than before,observation group was lower than control group,QOLS and MUNSH scores were significantly higher than before,observation group was higher than control group,the dif-ferences were statistically significant(P<0.05 of P<0.01). And there was no significant difference in the incidence of adverse reac-tions between 2 groups (P>0.05). CONCLUSIONS:Weifuchun tablet combined with rabeprazole enteric-coated tablet has better efficacy than only rabeprazole in the treatment of chronic gastritis with reflux esophagitis,it can relieve clinical symptoms of pa-tients,with better safety.